|Gene|Status| First BL study | Other lists | 
|:-:|:-:|:-:|:----|
|[ADAMTS5](ADAMTS5)|BL Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)||
|[ADNP](ADNP)|BL Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)||
|[AGO4](AGO4)|BL Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)||
|[ARHGEF1](ARHGEF1)|BL Tier 2|[Muppidi et al](papers/muppidiLossSignalingGa132014)||
|[B2M](B2M)|BL Tier 2|[Ma et al](papers/maSubtypespecificCooccurringGenetic2022)|[DLBCL](DLBCL_genes#tier-1-dlbcl-genes), [FL](FL_genes#tier-1-fl-genes), [PMBL](PMBL_genes#tier-1-pmbl-genes), [MCL](MCL_genes#tier-2-mcl-genes)|
|[BCL2](BCL2)|BL Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|[DLBCL](DLBCL_genes#tier-1-dlbcl-genes), [FL](FL_genes#tier-1-fl-genes), [PMBL](PMBL_genes#tier-2-pmbl-genes)|
|[BTG1](BTG1)|BL Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|[DLBCL](DLBCL_genes#tier-1-dlbcl-genes), [FL](FL_genes#tier-2-fl-genes), [PMBL](PMBL_genes#tier-1-pmbl-genes), [MZL](MZL_genes#tier-1-mzl-genes)|
|[C16orf48](C16orf48)|BL Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)||
|[CARD11](CARD11)|BL Tier 2|[Ma et al](papers/maSubtypespecificCooccurringGenetic2022)|[DLBCL](DLBCL_genes#tier-1-dlbcl-genes), [FL](FL_genes#tier-1-fl-genes), [MCL](MCL_genes#tier-1-mcl-genes), [MZL](MZL_genes#tier-1-mzl-genes)|
|[CARD4](CARD4)|BL Tier 2|[Love et al](papers/loveGeneticLandscapeMutations2012)||
|[CCNF](CCNF)|BL Tier 2|[Abate et al](papers/abateDistinctViralMutational2015)|[DLBCL](DLBCL_genes#tier-3-dlbcl-genes)|
|[CD79A](CD79A)|BL Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|[MZL](MZL_genes#tier-2-mzl-genes)|
|[CD83](CD83)|BL Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)|[DLBCL](DLBCL_genes#tier-1-dlbcl-genes), [FL](FL_genes#tier-1-fl-genes), [PMBL](PMBL_genes#tier-1-pmbl-genes)|
|[CDC27](CDC27)|BL Tier 2|[Ma et al](papers/maSubtypespecificCooccurringGenetic2022)||
|[CDC73](CDC73)|BL Tier 2|[Love et al](papers/loveGeneticLandscapeMutations2012)|[DLBCL](DLBCL_genes#tier-3-dlbcl-genes)|
|[CDKN2A](CDKN2A)|BL Tier 2|[Grande et al](papers/grandeGenomewideDiscoverySomatic2019)|[DLBCL](DLBCL_genes#tier-1-dlbcl-genes), [PMBL](PMBL_genes#tier-2-pmbl-genes), [MZL](MZL_genes#tier-2-mzl-genes)|
|[CDKN2C](CDKN2C)|BL Tier 2|[Thomas et al](papers/thomasGeneticSubgroupsInform2023)||
|[CHD4](CHD4)|BL Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)||
|[CPXM2](CPXM2)|BL Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)||
|[CXCR4](CXCR4)|BL Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)|[DLBCL](DLBCL_genes#tier-1-dlbcl-genes), [FL](FL_genes#tier-2-fl-genes), [MZL](MZL_genes#tier-1-mzl-genes)|
|[DHCR7](DHCR7)|BL Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)||
|[E2F2](E2F2)|BL Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)||
|[EBF1](EBF1)|BL Tier 2|[Thomas et al](papers/thomasGeneticSubgroupsInform2023)|[DLBCL](DLBCL_genes#tier-1-dlbcl-genes), [FL](FL_genes#tier-1-fl-genes), [PMBL](PMBL_genes#tier-1-pmbl-genes)|
|[EDNRB](EDNRB)|BL Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)||
|[EHD1](EHD1)|BL Tier 2|[Thomas et al](papers/thomasGeneticSubgroupsInform2023)||
|[EIF4A1](EIF4A1)|BL Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)||
|[ELP2](ELP2)|BL Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)||
|[EPPK1](EPPK1)|BL Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)||
|[ERAP1](ERAP1)|BL Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)||
|[EXOSC6](EXOSC6)|BL Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)||
|[FLYWCH1](FLYWCH1)|BL Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)||
|[GGTLA4](GGTLA4)|BL Tier 2|[Love et al](papers/loveGeneticLandscapeMutations2012)||
|[GTSE1](GTSE1)|BL Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)||
|[HIST1H1B](HIST1H1B)|BL Tier 2|[Ma et al](papers/maSubtypespecificCooccurringGenetic2022)|[DLBCL](DLBCL_genes#tier-1-dlbcl-genes), [FL](FL_genes#tier-1-fl-genes), [PMBL](PMBL_genes#tier-1-pmbl-genes)|
|[HIST1H3D](HIST1H3D)|BL Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)||
|[HIST1H3I](HIST1H3I)|BL Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)|[FL](FL_genes#tier-2-fl-genes)|
|[HIST1H4J](HIST1H4J)|BL Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)|[PMBL](PMBL_genes#tier-2-pmbl-genes)|
|[HLA-DQB1](HLA-DQB1)|BL Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)||
|[IKZF3](IKZF3)|BL Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)|[DLBCL](DLBCL_genes#tier-1-dlbcl-genes)|
|[IRF8](IRF8)|BL Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)|[DLBCL](DLBCL_genes#tier-1-dlbcl-genes), [FL](FL_genes#tier-1-fl-genes), [PMBL](PMBL_genes#tier-1-pmbl-genes)|
|[KANK2](KANK2)|BL Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)||
|[KLHL26](KLHL26)|BL Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)||
|[KMT2C](KMT2C)|BL Tier 2|[Zhou et al](papers/zhouSporadicEndemicBurkitt2019)|[DLBCL](DLBCL_genes#tier-1-dlbcl-genes), [PMBL](PMBL_genes#tier-1-pmbl-genes), [MCL](MCL_genes#tier-2-mcl-genes)|
|[MCL1](MCL1)|BL Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)|[DLBCL](DLBCL_genes#tier-2-dlbcl-genes), [PMBL](PMBL_genes#tier-2-pmbl-genes)|
|[MIR142](MIR142)|BL Tier 2|[Grande et al](papers/grandeGenomewideDiscoverySomatic2019)|[DLBCL](DLBCL_genes#tier-1-dlbcl-genes)|
|[MKI67](MKI67)|BL Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)|[FL](FL_genes#tier-2-fl-genes)|
|[MYO18A](MYO18A)|BL Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)||
|[NBEAL1](NBEAL1)|BL Tier 2|[Love et al](papers/loveGeneticLandscapeMutations2012)||
|[NCOR2](NCOR2)|BL Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)|[PMBL](PMBL_genes#tier-2-pmbl-genes), [MZL](MZL_genes#tier-1-mzl-genes)|
|[NOA1](NOA1)|BL Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)||
|[P2RY2](P2RY2)|BL Tier 2|[Love et al](papers/loveGeneticLandscapeMutations2012)||
|[PDCD11](PDCD11)|BL Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)||
|[PIM1](PIM1)|BL Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|[DLBCL](DLBCL_genes#tier-1-dlbcl-genes), [FL](FL_genes#tier-1-fl-genes), [PMBL](PMBL_genes#tier-1-pmbl-genes)|
|[PLCG2](PLCG2)|BL Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)|[DLBCL](DLBCL_genes#tier-3-dlbcl-genes)|
|[PPP6R2](PPP6R2)|BL Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)||
|[PRDM1](PRDM1)|BL Tier 2|[Ma et al](papers/maSubtypespecificCooccurringGenetic2022)|[DLBCL](DLBCL_genes#tier-1-dlbcl-genes)|
|[PREX1](PREX1)|BL Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)||
|[RANBP6](RANBP6)|BL Tier 2|[Love et al](papers/loveGeneticLandscapeMutations2012)||
|[REV3L](REV3L)|BL Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)||
|[RNF144B](RNF144B)|BL Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)||
|[RPL10](RPL10)|BL Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)||
|[S1PR2](S1PR2)|BL Tier 2|[Muppidi et al](papers/muppidiLossSignalingGa132014)|[DLBCL](DLBCL_genes#tier-1-dlbcl-genes), [FL](FL_genes#tier-2-fl-genes), [PMBL](PMBL_genes#tier-2-pmbl-genes)|
|[SAL3](SAL3)|BL Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)||
|[TBL1XR1](TBL1XR1)|BL Tier 2|[Ma et al](papers/maSubtypespecificCooccurringGenetic2022)|[DLBCL](DLBCL_genes#tier-1-dlbcl-genes), [FL](FL_genes#tier-1-fl-genes), [PMBL](PMBL_genes#tier-2-pmbl-genes), [MZL](MZL_genes#tier-1-mzl-genes)|
|[TET2](TET2)|BL Tier 2|[Thomas et al](papers/thomasGeneticSubgroupsInform2023)|[DLBCL](DLBCL_genes#tier-1-dlbcl-genes)|
|[TNFRSF14](TNFRSF14)|BL Tier 2|[Ma et al](papers/maSubtypespecificCooccurringGenetic2022)|[DLBCL](DLBCL_genes#tier-1-dlbcl-genes), [FL](FL_genes#tier-1-fl-genes), [MZL](MZL_genes#tier-1-mzl-genes)|
|[TOP2A](TOP2A)|BL Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)||
|[TTN](TTN)|BL Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)||
|[VWA7](VWA7)|BL Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)||
|[WDR90](WDR90)|BL Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)||
|[WHAMM](WHAMM)|BL Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)||
|[WNK2](WNK2)|BL Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)||
|[YY1AP1](YY1AP1)|BL Tier 2|[Schmitz et al](papers/schmitzBurkittLymphomaPathogenesis2012)||
|[ZAN](ZAN)|BL Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)||
|[ZBTB7A](ZBTB7A)|BL Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)|[DLBCL](DLBCL_genes#tier-3-dlbcl-genes)|
|[ZFP36L1](ZFP36L1)|BL Tier 2|[Panea et al](papers/paneaWholeGenomeLandscape2019)|[DLBCL](DLBCL_genes#tier-1-dlbcl-genes), [PMBL](PMBL_genes#tier-1-pmbl-genes)|
|[ZNF85](ZNF85)|BL Tier 2|[Burkhardt et al](papers/burkhardtClinicalRelevanceMolecular2022)||
